2CUREX vs HLUN-A: Side-by-Side Comparison
Compare 2cureX AB (2CUREX) and H Lundbeck A/S (HLUN-A) side by side: market cap SEK 46.39M vs DKK 36.21B. Financials, growth and model signals on Bullrun.
| Metric | 2CUREX | HLUN-A |
|---|---|---|
| Company | 2cureX AB | H Lundbeck A/S |
| Country / Exchange | Denmark · ST | Denmark · CO |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Drug Manufacturers - Specialty & Generic |
| Market cap | SEK 46.39M | DKK 36.21B |
| P/E ratio | — | 9.7 |
| Dividend yield | — | 3.15% |
| Valuation model | — | 75.3% undervalued |
| Revenue (latest FY) | SEK 0 | DKK 24.63B |
| Revenue growth YoY | — | +11.9% |
| Net income | SEK -4.55M | DKK 3.19B |
| Gross margin | — | 82.7% |
| Diluted EPS | -0.18 | 3.22 |
Figures are in each company's reporting currency — compare growth rates and margins rather than raw amounts.